I Mean this smells....why on earth would PAR be asking for more than their P1 and P2 objectives in that it involves non clinical data....it doesn't make sense!!!
"I am guessing that PAR are seeking a broader than we expected charter.If the non-clinical data is tied to either, then what is its nature, is it essential, what is its purpose, marketing material?"
Delay = Buy Opportunity, page-22
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.55M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 20.5¢ | $264.9K | 1.250M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 47501 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 4460 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |